scientific program - World Allergy Organization

More documents

Recommendations

Info

WEDNESDAY 84 WEDNESDAY, 10 SEPTEMBER- continued WAO Congress–XVIII ICACI Final Program P-15-7 IL-10 is possibly more important than IFN-gamma in the reduction of Th2 immune responses in the human peripheral blood mononuclear cells by ISS-ODNs Kang HR1 , Lee JY2 , Kim TB1 , Cho SH1 , Min KU1 , Kim YY1 1Internal Medicine, College of Medicine, Seoul National University, Seoul, Republic of Korea, 2Internal Medicine, College of Medicine, Hallym University, Seoul, Republic of Korea P-15-8 The influence of specific immunotherapy of bacterial antigens in complex in licopid on some parameters of immunity in patient with bacterial allergy Baranova NI1 , Molotilov BA1 1The Institute of Postgraduate Medical Studies, Penza, Russian Federation P-15-9 Clinical efficacy and safety of omalizumab on seasonal allergic rhinitis (SAR) induced by Japanese cedar pollen in the second pollen season Okubo K1 , Ogino S2 , Nagakura T3 , Ishikawa T4 1 2 Nippon Medical School, Tokyo, Japan, Osaka University, Osaka, Japan, 3Yoga Allergy Clinic, Tokyo, Japan, 4Kumamoto University, Kumamoto, Japan P-15-10 Hymenoptera venom immunotherapy does not cause proteinuria Nusem D1 , Panasoff J2 1Western Galilee Hospital-Nahariya and Lin Medical Center-Allergy Dept., Nahariya-Haifa, Israel, 2Clalit Health Services-Lin Medical Center-Allergy Dept., Haifa, Israel P-15-11 In vitro evidence of immunosuppressive effect of Kupffer cells Chen YLC1 , Chung SWC1 , Mui AM1 , Ong CO1 1General Surgery Department, University of British Columbia, Vancouver, BC, Canada P-15-12 Specific immunotherapy combined with immunomodulator Superlymph in patients with allergy to house dust mites Mityaseva SA1 , Polner SA1 , Kovalchuk LV1 , Chervinskaya TA1 1Institute of Immunology, Moscow, Russian Federation P-15-13 Specific immunotherapy of allergic diseases: a three-year prospective observational study Barbatano Enzo BE1 1Private Surgery of Pneumology, Giarre, Catania, Italy P-15-14 Immunotherapy suppressed histamine release rate from basophils Yuta A1 , Majima Y1 1Dept of Otorhinolaryngology, Mie University, Tsu, Mie, Japan P-15-15 Safety and tolerability of allergoid sublingual immunotherapy in patients with allergic rhinoconjunctivitis, rhinitis and/or asthma Bernardis P1 1ULSS 16 - Allergologic surgery, Padova, PD, Italy P-15-16 Clinical outcome of asthma specific immunotherapy and spirometric patterns Palma-Carlos AG1 , Palma-Carlos ML2 1I Medical Clinic, Lisbon University Hospital, Immuno-Allergology, Lisboa, Portugal, 2CHIUL - Universidade de Lisboa, Lisboa, Portugal P-15-17 Evaluation of immunotherapy by immunoblotting methods Palma-Carlos ML1 , Pereira Santos MC1 , Murta R1 , Pedro E2 , Spinola Santos A2 , Lopes Pregal A2 , Branco-Ferreira M2 , Palma- Carlos AG2 1 2 CHIUL, Lisbon University, Lisbon, Portugal, Inst. Immunology, Immunoallergology Unit, Fac. Med. Lisboa, Lisboa, Portugal POSTER SESSIONS P-15-18 Effect of specific immunotherapy on nasal reactivity to allergen challenge Palma-Carlos AG1 , Palma-Carlos ML2 1Faculty of Medicine, Hospital de Santa Maria, Immuno-Allergology Unit, Lisboa, Portugal, 2CHIUL - Universidade de Lisboa, Lisboa, Portugal P-15-19 Immunotherapy impact on asthma quality of life: two-year follow-up Roger A1 , Dordal MT1 , Alias C1 , Serra R1 , Vila B1 , Martí E1 1H. U. Germans Trias i Pujol, Badalona, Catalonia, Spain O-14-6 Improving the safety of immunotherapy by pretreatment with fexofenadine Ohashi Y1 , Nakai Y2 , Murata K2 1 2 Ishikiri-Seiki Hospital, Osaka, Japan, Kinki University, Osaka, Japan P-15-21 Ten years experience of Rybomunil application in clinics of the Institute of Immunology, Moscow, Russia Klevtsova MN1 1Institute of Immunology, Moscow, Russian Federation P-15-22 Local and systemic side effects of allergen injection immunotherapy Yazicioglu M1 , Ulker O2 , Guler N2 1Department of Pediatrics, Trakya University, Edirne, Turkey, 2Division of Allergy, Department of Pediatrics, Istanbul University, Istanbul, Turkey P-15-23 Conventional immunotherapy versus sublingual immunotherapy with standardized five-grass pollen in children with seasonal allergic rhinoconjunctivitis Karakoc GK1 , Altintas D1 , Yilmaz M1 , Kendirli SG1 1Cukurova University, Faculty of Medicine, Pediatric Allergy- Immunology, Adana, Turkey P-15-24 Evaluation of sublingual immunotherapy in asthmatic patients Hanna KM1 , Hanna WM2 , Gomaa BH1 1 2 Faculty of Medicine Cairo University, Cairo, Egypt, National Research Center, Cairo, Egypt P-15-25 Clinical comparison between two pre-seasonal schedules of allergen specific immunotherapy: efficacy and tolerability Giovannini M1 1Pulmonary and Allergic Diseases Dept., Lugo Ravenna, Italy P-15-26 Efficacy and safety of DEPIGOID, a depigmented polymerized allergen extract Sager A1 , Renner BGR1 1LETI Pharma, Witten, Germany P-15-27 Immunotherapy to mold is a gate to control recurrent vulvovaginal infections Koshak EA1 1King Abdulaziz University Hospital, Jeddah, Seychelles P-15-28 Effect of immunotherapy on complement activation in ragweed allergic patients Dervaderics MD1 , Fust GF2 , Varga LV2 1 2 SOTE PhD Scool, Budapest, Hungary, SOTE Research Lab, Budapest, Hungary
WAO Congress–XVIII ICACI Final Program WEDNESDAY, 10 SEPTEMBER- continued POSTER SESSIONS P-15-29 Modulation of allergic response by chemically modified allergen and immunomodulator Polyoxidonium Babakhin AA1 , Andreev SM1 , Petrukhina AO1 , Puchkova NI1 , Khaitov RM1 , DuBuske LM2 , Petrov RV1 1National Research Center - Institute of Immunology, Moscow, Russian Federation, 2Immunology Research Institute of New England, Fitchburg, MA, USA P-15-30 Modulation of the IgE response to Alternaria after DNA vaccination with the major Alternaria allergens (rAlta1 and rAlta2) in a brown Norway rat model Montalbano MM1 , Sanchez H2 , Keyes EL2 , Rosenthal LA1 , Sorkness RL3 , Bush RK1 1University of Wisconsin Medical School, Madison, WI, USA, 2William S Middleton VA Medical Center, Madison, WI, USA, 3University of Wisconsin-Madison School of Pharmacy, Madison, WI, USA Rhinosinusitis P-16-1 The prospective and retrospective significance of surgical correction of obstructive changes in the nasopharynx had improved not only nocturnal snoring Ishaq IM1 1Al-Junaid Hospital, Nowshera, NWFP, Pakistan P-16-2 Diagnosis & management care in a limited resource of a primary care setting Jamal EJ1 1University Putra Malaysia, Kuala Lumpur, Selangor, Malaysia P-16-3 Efficacy and safety of mometasone furoate nasal spray for prophylactic treatment of intermittent moderate/severe allergic rhinitis Papadopoulos NG1 , Papadopoulos D2 , Kompoti E3 , Manoussakis E1 , Tassios I1 , Pitsios K3 , Baibas N4 , Kontou-Fili K3 , Saxoni- Papageorgiou P5 1Allergy Department, 2nd Pediatric Clinic, Univ. of Athens, Athens, Greece, 2 "424" General Army Hospital, Thessaloniki, Greece, 3 4 Laikon General Hospital, Athens, Greece, Epidemiology Dept., Univ. of Athens, Athens, Greece, 5Allergy Department, Univ. of Athens, Athens, Greece P-16-4 The content of fatty acids in erythrocyte membranes in pollinosis children in long remission period Terechtchenko S1 , Babushkin V2 , Terechtchenko V2 1State Medical Research Institute for Northern Problems, Krasnoyarsk, Russian Federation, 2State Krasnoyarsk Medical Academy, Krasnoyarsk, Russian Federation P-16-5 A virtual model for human nasal mucosa and the influence of individual specific allergic reactions Strauss GS1 , Winkler DW2 , Nowatius EN3 , Mueller HM1 1Dept. of Otorhinolaryngology/University of Leipzig, Leipzig, Germany, 2Dept. of Neurosurgery/University of Leipzig, Leipzig, Germany, 3Zwonull Inc., Leipzig, Germany P-16-6 Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local glucocorticoid Sergejeva S1 , Lotvall Jtvall J> 1 , Pullerits T1 1Lung Pharmacology Group, Göteborg University, Gothenburg, Sweden P-16-7 Allergic rhinitis in Delhi: a comparative profile of “sneezers and runners” and “blockers” Khanna P1 , Shah A1 1V P Chest Institute, University of Delhi, Delhi, India P-16-8 Early revealings of allergic rhinitis Chopyak V 1 , Lishchuk K 1 1 Lviv State Medical University, Lviv, Ukraine 85 P-16-9 Seasonal allergic rhinitis (SAR) - circadian variation - timing of desloratadine (DL) dosing Haye R1 , Hoye Kye K> 2 , Berg O3 , Frones Snes S> 4 , Ädegård T4 1 2 Rikshospitalet, Oslo, Norway, Helsetorget Legesenter, Elverum, Norway, 3Betania, Stockholm, Sweden, 4Schering-Plough, Eiksmarka, Norway P-16-10 Prevalence of allergic rhinitis among asthmatics in eastern India Jodhani K1 , Barman NN2 1 2 Asthma Allergy Center, Guwahati, Assam, India, Guwahati Medical College, Guwahati, Assam, India P-16-11 Allergic rhinitis: diagnosis and misdiagnosis Krupski MH1 , Tshifularo MI1 , Vorster W1 1Medunsa - Medical University of South Africa, Pretoria, Gauteng, South Africa P-16-12 Genetic variants of ADAM33 in Japanese cedar pollinosis Cheng L1 , Enomoto T2 , Shimizu M3 , Hirota T3 , Tamari M3 , Shirakawa T1 1Department of Health Promotion and Human Behavior, Kyoto University, Kyoto, Japan, 2Department of ORL, Japanese Red Cross Society Wakayama Medical Center, Wakayama, Japan, 3Laboratory for Genetics of Allergic Disease, RIKEN SNP Research Center, Yokohama, Japan P-16-13 Intracellular cytokines in T helper cells in intermittent allergic rhinitis Glück J1 , Mazur B2 , Rogala B1 1Chair & Dept. of Internal Diseases, Allergology and Cli. Immunol, Zabrze, Poland, 2Dept. of Pathophysiology, Zabrze, Poland P-16-14 Evaluation of the safety and efficacy of oral fexofenadine in pediatric subjects with seasonal allergic rhinitis: pooled analysis of three studies Meltzer E1 , Scheinmann P2 , Rosado Pinto J3 , Bachert C4 , Hedlin G5 , Wahn U6 , Finn A7 , Ruuth E8 1Allergy and Asthma Medical Group and Research Center, San Diego, California, USA, 2Groupe Hospitalier Necker-Enfants Malades, Paris, France, 3Dona Estefania Hospital, Lisbon, Portugal, 4 5 Ghent University, Ghent, Belgium, Karolinska Institutet, Stockholm, Sweden, 6University Children’s Hospital, Berlin, Germany, 7National Allergy, Asthma and Urticaria Centers, Charleston, SC, USA, 8Aventis Pharma, Romainville, France P-16-15 Fexofenadine effectively relieves seasonal allergic rhinitis in children from the South American Cone Baena-Cagnani C1 , Neffen H2 , Maspero J3 , Lisanti M4 , Portes R5 , Hardy P6 , Ruuth E6 1 2 Hospital Infantil Municipal, Cordoba, Argentina, Centro de Alergia e Inmunologia, Sante Fe, Argentina, 3Hospital Ricardo Gutierrez, Capital Federal, Argentina, 4Instituto de Alergia e Immunologia, Mendoza, Argentina, 5Centro de Asma, Alergia y Immunologia Quilmes, Provincia de Buenos Aires, Argentina, 6Aventis Pharma, Paris, France P-16-16 Fexofenadine effectively relieves seasonal allergic rhinitis in children sensitized to a wide range of pollen categories Baena-Cagnani C 1 , Bernstein D 2 , Emeryck A 3 , Lisanti M 4 , Potter P 5 , Finn A 6 , Hardy P 7 , Ruuth E 7 1 Hospital Infantil Municipal, Cordoba, Argentina, 2 Bernstein Clinical Research Center, Cincinnati, Ohio, USA, 3 Klinika Pulmonogii - CSK AM, Lublin, Poland, 4 Instituto de Alergia e Immunologia, Mendoza, Argentina, 5 University of Capetown, Mowbray, South Africa, 6 National Allergy, Asthma and Urticaria Centers, Charleston, South Carolina, USA, 7 Aventis Pharma, Paris, France WEDNESDAY
Page 1:
FINAL PROGRAM World Allergy Organiz
Page 4 and 5:
2 WAO Congress-XVIII ICACI Final Pr
Page 6 and 7:
4 World Allergy Organization (WAO)-
Page 8 and 9:
6 WAO Congress-XVIII ICACI Final Pr
Page 10 and 11:
8 sneezing runny nose itchy nose it
Page 12 and 13:
10 PRECAUTIONS (continued) ADVERSE
Page 14 and 15:
12 WAO Congress-XVIII ICACI Final P
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 23 and 24:
WAO Congress-XVIII ICACI Final Prog
Page 25 and 26:
Whistler alpine resort WAO Congress
Page 27 and 28:
Page 29 and 30:
XXIII EAACI Congress 12-16 June 200
Page 31 and 32:
7:00 8:00 9:00 10:00 11:00 12:00 13
Page 33 and 34:
Page 35 and 36: WAO Congress-XVIII ICACI Final Prog
Page 49 and 50: WEDNESDAY WEDNESDAY SEPTEMBER SEPTE
Page 51 and 52: www.annualmeeting.aaaai.org Visit w
Page 59 and 60: Presenting authors indicated in bol
Page 61 and 62: FRIDAY, 12 SEPTEMBER WAO Congress-X
Page 63 and 64: Imagine research targeting IgE, a k
Page 85: WAO Congress-XVIII ICACI Final Prog
Page 98 and 99: 96 PLAN TO ATTEND! SOYEZ DES NÔTRE
Page 100 and 101: 98 Dolovich, Myrna Canada BR86 Dubo
Page 102 and 103: 100 Schnuch, Axel Germany BR88 Scho
Page 104 and 105: 102 201 ACII - Journal of the World
Page 106 and 107: 104 WAO Congress-XVIII ICACI Final
Page 116 and 117: 114 Crowne Plaza Hotel Georgia 801
Page 120 and 121: 118 (salmeterol xinafoate/fluticaso
Page 122 and 123: COPD, the most commonly reported dr
Page 126 and 127: 124 Seaplane landing at sunset Gran
Page 128: DS2 - Dinner Symposium Monday, 8 Se
show all

scientific program - World Allergy Organization

Create successful ePaper yourself

Delete template?

Save as template?